Advertisement

MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Authors

  • Silvia Giordano,

    Corresponding author
    1. Institute for Cancer Research at Candiolo, University of Torino Medical School, Turin, Italy
    • Department of Oncology, University of Torino, Medical School, Institute for Cancer Research at Candiolo, Strada Provinciale 142, Candiolo (Torino), 10060, Italy
    Search for more papers by this author
    • fax (39)-011-9933225

  • Amedeo Columbano

    Corresponding author
    1. Department of Biomedical Sciences, Unit of Oncology and Molecular Pathology, University of Cagliari, Cagliari, Italy
    • Department of Biomedical Sciences, Unit of Oncology and Molecular Pathology, University of Cagliari, Via Porcell 4, 09124 Cagliari, Italy
    Search for more papers by this author
    • fax: (39)-070-666062


  • Potential conflict of interest: Nothing to report.

Abstract

MicroRNAs (miRNAs) are evolutionarily conserved small noncoding RNAs involved in the regulation of gene expression and protein translation. Many studies have shown that they play a crucial role in driving organ and tissue differentiation during embryogenesis and in the fine-tuning of fundamental biological processes, such as proliferation and apoptosis. Growing evidence indicates that their deregulation plays an important role in cancer onset and progression as well, where they act as oncogenes or oncosuppressors. In this review, we highlight the most recent findings regarding the role of miRNAs in hepatocellular carcinoma (HCC) by analyzing the possible mechanisms by which they contribute to this neoplasm. Moreover, we discuss the possible role of circulating miRNAs as biomarkers, a field that needs urgent improvement in the clinical surveillance of HCC, and the fascinating possibility of using them as therapeutic targets or drugs themselves. (HEPATOLOGY 2013)

Ancillary